New Drug Target for Treating Idiopathic Pulmonary Fibrosis
A closer look into discoidin domain receptors lead to the development of a novel inhibitor with better anti-fibrotic effect. Idiopathic pulmonary fibrosis (IPF) is a chronic fatal lung disease, where...